Asia Pacific Wearable Cardioverter Defibrillator Market size was around USD XX billion in 2017. It is expected to grow at a CAGR of XX% to reach USD XX billion by 2022. Wearable cardioverter defibrillator is a gadget that is non-invasive it is utilized to prevent sudden heart attack. It has two parts: A light weight jacket which is worn under regular clothes and a small mobile unit which includes recorder and generator. Sudden heart attack occurs when the heart's electrical system malfunctions. It directs the heart to relax and contract. Those conditions where there is abnormal rhythm in the ventricles of the heart is known as Ventricular Fibrillation. When VF occurs, a WCD sends an electrical current to the heart that is used to revive a normal heart rhythm. Defibrillators are used for the treatment of life-threatening ventricular fibrillation, heart dysrhythmias, and ventricular tachycardia.
Rising prevalence of diseases, increasing geriatric population, growing number of training and awareness among the population base and, technological advancements are the primary drivers of the market.On the other hand, factors like problems related to the use of wearable cardioverter defibrillator devices, inadequate knowledge regarding sudden cardiac arrest, and the wearable cardioverter defibrillator does not monitor atrial arrhythmias thus this hinders the growth of the market.
Asia Pacific Wearable Cardioverter Defibrillator Market Segmentation by Conditions and by End User. By Conditions it is segmented into Peripartum Cardiomyopathy, Congenital Heart Disease, and Inherited Arrhythmias. By End User the market is segmented into Hospitals, Home Care Settings, and Cardiology Clinics.
Asia Pacific Wearable Cardioverter Defibrillator Market geographical segmentation by India, China, Korea, Japan and others. The Market is majorly driven by rise in demand from developing economies in the Asia Pacific regions, where more workstations and business environments are introducing advancement in defibrillators. It is projected to benefit the defibrillators market in the aforementioned forecast period.
The major Asia Pacific Wearable Cardioverter Defibrillator Market leaders are LivaNova PLC (U.K.), Koninklijke Philips N.V. (Netherlands), ZOLL Medical Corporation (U.S.), Cardiac Science Corporation (U.S.), Physio-Control, Inc. (U.S.), Medtronic PLC (Ireland), St. Jude Medical, Inc. (U.S.), Boston Scientific Corporation (U.S.), BIOTRONIK SE & Co. KG (Germany), and Nihon Kohden Corporation (Japan)
1. Introduction
1.1 Market Definition
1.2 Study Deliverables
1.3 Base Currency, Base Year and Forecast Periods
1.4 General Study Assumptions
2. Research Methodology
2.1 Introduction
2.2 Research Phases
2.2.1 Secondary Research
2.2.2 Primary Research
2.2.3 Econometric Modelling
2.2.4 Expert Validation
2.3 Analysis Design
2.4 Study Timeline
3. Overview
3.1 Executive Summary
3.2 Key Inferences
3.3 Epidemology
4. Drivers, Restraints, Opportunities, and Challenges Analysis (DROC)
4.1 Market Drivers
4.2 Market Restraints
4.3 Key Challenges
4.4 Current Opportunities in the Market
5. Market Segmentation
5.1 Conditions
5.1.1 Introduction
5.1.2 Peripartum Cardiomyopathy
5.1.3 Congenital Heart Disease
5.1.4 Inherited Arrhythmias
5.1.5 Y-o-Y Growth Analysis, By Conditions
5.1.6 Market Attractiveness Analysis, By Conditions
5.1.7 Market Share Analysis, By Conditions
5.2 End User
5.2.1 Introduction
5.2.2 Hospitals
5.2.3 Home Care Settings
5.2.4 Cardiology Clinics
5.2.5 Y-o-Y Growth Analysis, By End User
5.2.6 Market Attractiveness Analysis, By End User
5.2.7 Market Share Analysis, By End User
6. Geographical Analysis
6.1 Introduction
6.1.1 Regional Trends
6.1.2 Impact Analysis
6.1.3 Y-o-Y Growth Analysis
6.1.3.1 By Geographical Area
6.1.3.2 By Conditions
6.1.3.3 By End User
6.1.4 Market Attractiveness Analysis
6.1.4.1 By Geographical Area
6.1.4.2 By Conditions
6.1.4.3 By End User
6.1.5 Market Share Analysis
6.1.5.1 By Geographical Area
6.1.5.2 By Conditions
6.1.5.3 By End User
6.2 China
6.3 India
6.4 Japan
6.5 South Korea
6.6 Australia
7. Strategic Analysis
7.1 PESTLE analysis
7.1.1 Political
7.1.2 Economic
7.1.3 Social
7.1.4 Technological
7.1.5 Legal
7.1.6 Environmental
7.2 Porter’s Five analysis
7.2.1 Bargaining Power of Suppliers
7.2.2 Bargaining Power of Consumers
7.2.3 Threat of New Entrants
7.2.4 Threat of Substitute Products and Services
7.2.5 Competitive Rivalry within the Industry
8. Market Leaders' Analysis
8.1 ZOLL Medical Corporation
8.1.1 Overview
8.1.2 Product Analysis
8.1.3 Financial analysis
8.1.4 Recent Developments
8.1.5 SWOT analysis
8.1.6 Analyst View
8.2 Medtronic PLC (Ireland)
8.3 St. Jude Medical
8.4 Boston Scientific Corporation (U.S.)
8.5 BIOTRONIK SE & Co. KG (Germany)
8.6 LivaNova PLC (U.K.)
8.7 Koninklijke Philips N.V. (Netherlands)
8.8 Cardiac Science Corporation (U.S.)
8.9 Physio-Control
8.10 Nihon Kohden Corporation (Japan)
9. Competitive Landscape
9.1 Market share analysis
9.2 Merger and Acquisition Analysis
9.3 Agreements, collaborations and Joint Ventures
9.4 New Product Launches
10. Market Outlook and Investment Opportunities
Appendix
a) List of Tables
b) List of Figures
